Heterogeneity of Treatment Response to Citalopram for Patients With Alzheimer's Disease With Aggression or Agitation: The CitAD Randomized Clinical Trial

The American Journal of Psychiatry
Lon S SchneiderCitAD Research Group

Abstract

Pharmacological treatments for agitation and aggression in patients with Alzheimer's disease have shown limited efficacy. The authors assessed the heterogeneity of response to citalopram in the Citalopram for Agitation in Alzheimer Disease (CitAD) study to identify individuals who may be helped or harmed. In this double-blind parallel-group multicenter trial of 186 patients with Alzheimer's disease and clinically significant agitation, participants were randomly assigned to receive citalopram or placebo for 9 weeks, with the dosage titrated to 30 mg/day over the first 3 weeks. Five planned potential predictors of treatment outcome were assessed, along with six additional predictors. The authors then used a two-stage multivariate method to select the most likely predictors; grouped participants into 10 subgroups by their index scores; and estimated the citalopram treatment effect for each. Five covariates were likely predictors, and treatment effect was heterogeneous across the subgroups. Patients for whom citalopram was more effective were more likely to be outpatients, have the least cognitive impairment, have moderate agitation, and be within the middle age range (76-82 years). Patients for whom placebo was more effective wer...Continue Reading

Citations

May 28, 2016·Expert Opinion on Investigational Drugs·Ricardo P GarayPierre-Michel Llorca
Dec 3, 2014·Clinical Therapeutics·Erin K Zahradnik, Hillel Grossman
Mar 17, 2017·Expert Opinion on Pharmacotherapy·Anton P Porsteinsson, Inga M Antonsdottir
Jun 25, 2019·Current Treatment Options in Neurology·John M Ringman, Lon Schneider
Aug 20, 2019·Statistics in Medicine·Aniek Sies, Iven Van Mechelen
Oct 8, 2019·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Stephan EhrhardtUNKNOWN S-CitAD Research Group
Mar 17, 2020·Annals of Internal Medicine·Calvin Hirsch
Jun 2, 2020·Expert Opinion on Pharmacotherapy·Madia LozuponeFrancesco Panza
Jul 12, 2019·The Mental Health Clinician·Jamie L McCarrellAmie Taggart Blaszczyk
Apr 27, 2017·Frontiers in Aging Neuroscience·Walter J Lukiw, Evgeny I Rogaev
May 18, 2019·Drugs in R&D·Stephanie V PhanSusan C Fagan
Aug 9, 2019·Current Psychiatry Reports·Jeffrey CummingsKasia Rothenberg
Jan 6, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Vladimir KhavinsonSvetlana Trofimova
Sep 18, 2021·Neurology and Therapy·Ping LinJianqun Gao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

JAMA : the Journal of the American Medical Association
Anton P PorsteinssonCitAD Research Group
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
Lon S SchneiderPhilip Insel
© 2022 Meta ULC. All rights reserved